ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 984,93
-0,99%
Dow Jones
37 900,06
0,22%
DAX
17 932,17
-1,10%
Brent Oil
83,625
-2,64%
Bitcoin
56 956,30
-6,01%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Sophia Genetics SA (SOPH)

  7. Sophia Genetics SA (SOPH) Actualités

SOPH

Sophia Genetics (SOPH)

Sophia Genetics SA
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SOPH
DateHeureSourceTitreSymboleSociété
30/04/202413h05GlobeNewswire Inc.SOPHiA GENETICS to Present at the 2024 RBC Capital Markets Global Healthcare ConferenceNASDAQ:SOPHSophia Genetics SA
23/04/202416h29GlobeNewswire Inc.SOPHiA GENETICS to Announce Financial Results for First Quarter 2024 on May 7, 2024NASDAQ:SOPHSophia Genetics SA
23/04/202411h05PR Newswire (US)SOPHiA GENETICS Announces Syndicate Bio as First Liquid Biopsy Customer in AfricaNASDAQ:SOPHSophia Genetics SA
17/04/202412h05PR Newswire (US)SOPHiA GENETICS Announces Unilabs is using its AI Technology to Detect Homologous Recombination Deficiency (HRD)NASDAQ:SOPHSophia Genetics SA
04/04/202407h00PR Newswire (US)SOPHiA GENETICS and Strand Life Sciences Announce New Strategic PartnershipNASDAQ:SOPHSophia Genetics SA
02/04/202416h00PR Newswire (US)Laboratorio Barnafi-Krause is Live on SOPHiA DDM™NASDAQ:SOPHSophia Genetics SA
20/03/202415h00PR Newswire (US)SOPHiA GENETICS Announces First Homologous Recombination Deficiency (HRD) Customer in CanadaNASDAQ:SOPHSophia Genetics SA
15/03/202411h00PR Newswire (US)SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear CollaborationNASDAQ:SOPHSophia Genetics SA
07/03/202418h07GlobeNewswire Inc.SOPHiA GENETICS to Present at the Barclays 26th Annual Global Healthcare ConferenceNASDAQ:SOPHSophia Genetics SA
05/03/202413h02Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]NASDAQ:SOPHSophia Genetics SA
05/03/202413h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SOPHSophia Genetics SA
05/03/202412h45GlobeNewswire Inc.SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 ResultsNASDAQ:SOPHSophia Genetics SA
22/02/202414h45GlobeNewswire Inc.SOPHiA GENETICS to Participate in Fireside Chat at the 44th Annual TD Cowen Health Care ConferenceNASDAQ:SOPHSophia Genetics SA
20/02/202416h46GlobeNewswire Inc.SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full-Year 2023 on March 5, 2024NASDAQ:SOPHSophia Genetics SA
07/02/202413h31PR Newswire (US)SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in SpainNASDAQ:SOPHSophia Genetics SA
25/01/202416h50PR Newswire (US)SOPHiA GENETICS Supports Genetic Testing in BrazilNASDAQ:SOPHSophia Genetics SA
18/01/202421h00PR Newswire (US)SOPHiA GENETICS Enhances RareCyte Precision Biology Services PortfolioNASDAQ:SOPHSophia Genetics SA
15/01/202405h00PR Newswire (US)SOPHiA GENETICS and Karkinos Healthcare Forge Strategic Partnership to Advance Cancer Research in IndiaNASDAQ:SOPHSophia Genetics SA
10/01/202423h15PR Newswire (US)SOPHiA GENETICS Highlights Near-Term Growth Strategy at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:SOPHSophia Genetics SA
08/01/202415h08PR Newswire (US)Exactis Innovation and SOPHiA GENETICS Announce Collaboration on Multimodal Data AnalyticsNASDAQ:SOPHSophia Genetics SA
21/12/202313h00PR Newswire (US)Hôpital Saint-Louis Implements SOPHiA DDM™ Platform to Further Research of Myeloid DisordersNASDAQ:SOPHSophia Genetics SA
14/12/202318h43GlobeNewswire Inc.SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare ConferenceNASDAQ:SOPHSophia Genetics SA
07/12/202315h01PR Newswire (US)SOPHiA GENETICS Announces Expanded Suite of Liquid Biopsy OfferingsNASDAQ:SOPHSophia Genetics SA
30/11/202313h01PR Newswire (US)SOPHiA GENETICS Announces Expansion of Work with CHU de NîmesNASDAQ:SOPHSophia Genetics SA
28/11/202313h00PR Newswire (US)SOPHiA GENETICS Expands Relationship with Città della Salute e della Scienza di TorinoNASDAQ:SOPHSophia Genetics SA
17/11/202313h45PR Newswire (US)The Institute of Human Genetics, Polish Academy of Sciences (IHG PAS) is Live on SOPHiA GENETICSNASDAQ:SOPHSophia Genetics SA
07/11/202312h45PR Newswire (US)BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™NASDAQ:SOPHSophia Genetics SA
07/11/202312h30GlobeNewswire Inc.SOPHiA GENETICS Reports Financial Results for the Third Quarter of Fiscal 2023NASDAQ:SOPHSophia Genetics SA
24/10/202311h50GlobeNewswire Inc.SOPHiA GENETICS to Announce Financial Results for the Third Quarter of Fiscal 2023 on November 7, 2023NASDAQ:SOPHSophia Genetics SA
18/10/202314h00PR Newswire (US)SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer CareNASDAQ:SOPHSophia Genetics SA
 Showing the most relevant articles for your search:NASDAQ:SOPH

Dernières Valeurs Consultées

EU
ORA
Orange
NYSE
JPM
JP Morgan Chase
EU
ACA
Credit Agricole
EU
RI
Pernod Ricard
EU
GLE
Societe Generale
EU
EN
Bouygues
EU
HO
Thales
EU
PX4
SBF 120
EU
MC
Lvmh Moet Hennessy Louis...
NYSE
KO
Coca Cola
FTSE
UKX
FTSE 100
COIN
BTCUSD
Bitcoin
EU
RNO
Renault
EU
BNP
BNP Paribas
EU
SGO
Cie de SaintGobain
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés